Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease-Reference-Cited by-同舟云学术

Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease

Published:2021-05-04 Issue:8 Volume:36 Page:1972-1978
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Kremer Thomas¹,Taylor Kirsten I.¹²,Siebourg‐Polster Juliane³,Gerken Thomas⁴,Staempfli Andreas⁵,Czech Christian¹,Dukart Juergen¹⁶⁷,Galasko Douglas⁸,Foroud Tatiana⁹,Chahine Lana M.¹⁰,Coffey Christopher S.¹¹,Simuni Tanya¹²,Weintraub Daniel¹³^ORCID,Seibyl John¹⁴,Poston Kathleen L.¹⁵^ORCID,Toga Arthur W.¹⁶,Tanner Caroline M.¹⁷¹⁸,Marek Kenneth¹⁴¹⁹,Hutten Samantha J.¹⁹,Dziadek Sebastian¹,Trenkwalder Claudia²⁰²¹,Pagano Gennaro¹,Mollenhauer Brit²¹²²

Affiliation:

1. Roche Pharmaceutical Research and Early Development, NRD Neuroscience and Rare Diseases, Roche Innovation Center Basel F. Hoffmann–La Roche Ltd. Basel Switzerland

2. Faculty of Psychology University of Basel Basel Switzerland

3. Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel F. Hoffmann–La Roche Ltd. Basel Switzerland

4. Metanomics Health GmbH Berlin Germany

5. Roche Pharmaceutical Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel F. Hoffmann–La Roche Ltd. Basel Switzerland

6. Institute of Neuroscience and Medicine, Brain & Behaviour (INM‐7) Research Centre Jülich Julich Germany

7. Institute of Systems Neuroscience, Medical Faculty Heinrich Heine University Düsseldorf Düsseldorf Germany

8. Department of Neurosciences University of California, San Diego San Diego California USA

9. Department of Medical and Molecular Genetics Indiana University School of Medicine Indianapolis Indiana USA

10. Department of Neurology University of Pittsburgh Pittsburgh Pennsylvania USA

11. Department of Biostatistics, College of Public Health University of Iowa Iowa City Iowa USA

12. Parkinson's Disease and Movement Disorders Center Northwestern University Feinberg School of Medicine Chicago Illinois USA

13. Department of Neurology Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

14. Institute for Neurodegenerative Disorders New Haven Connecticut USA

15. Department of Neurology & Neurological Sciences School of Medicine, Stanford University Stanford California USA

16. Laboratory of Neuro Imaging University of Southern California (USC) Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of University of Southern California Los Angeles California USA

17. Department of Neurology University of California, San Francisco San Francisco California USA

18. Parkinson's Disease Research Education and Clinical Center, San Francisco Veterans Affairs Health Care System San Diego California USA

19. The Michael J. Fox Foundation for Parkinson's Research New York New York USA

20. Department of Neurosurgery University Medical Center Göttingen Göttingen Germany

21. Paracelsus‐Elena‐Klinik Kassel Germany

22. Department of Neurology University Medical Center Göttingen Göttingen Germany

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28608

Reference34 articles.

1. Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease

2. Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen Systems

3. Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease

4. Cerebrospinal fluid biomarkers in Parkinson disease

5. CSF in Alzheimer's Disease

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Empagliflozin repurposing in Parkinson’s disease; modulation of oxidative stress, neuroinflammation, AMPK/SIRT-1/PGC-1α, and wnt/β-catenin pathways;Inflammopharmacology;2023-12-01

2. How should we be using biomarkers in trials of disease modification in Parkinson’s disease?;Brain;2023-08-03

3. Effects of vaginal microbiota transfer on the neurodevelopment and microbiome of cesarean-born infants: A blinded randomized controlled trial;Cell Host & Microbe;2023-07

4. Simultaneous quantification of biogenic amines as biomarkers for Parkinson's disease by combining ultraviolet and integrated pulsed amperometric detectors;2023-04-25

5. Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes;Journal of Neural Transmission;2023-03-04